Home » Newsletters » BioWorld Science

BioWorld Science

May 23, 2000

View Archived Issues

AxyS subsidiary completes merger with Discovery Partners

Rebetol now available in France for HCV

Oxigene and Techniclone sign joint venture for vascular targeting therapies

GenStar acquires lentiviral vectors, AIDS vaccine

Aventis updates R&D activities --pipeline "full and delivering"

Vaccination with TAP1 gene promotes immune response to small cell lung cancer

Frequency of adverse events due to photodynamic therapy called into question

MoliChem Medicines reports successful result of phase I trial evaluating potential CF treatment

Start of phase I trial of HCT-3012 triggers milestone payment to NicOx

Neutralase studied in percutaneous coronary intervention trial

Metabolex signs second diabetes collaboration with Parke-Davis

Cyclopentenone-based antitumor agents synthesized in China

Agents for T. cruzi infection in development at Shenyang Pharmaceutical U.

Immtech to establish research consortium for leishmaniasis therapy

Company Profile: Enanta

Bayer introduces new allergic rhinitis Rx today in Japan

Vaccines for protecting against H. pylori infection disclosed by Chiron Behring

Combination therapies for allergic conditions under study at Schering-Plough

Safe and effective bronchodilators presented by Nippon Zoki

Preparation and use of pyridazines for asthma and related disorders

4,5-Dihydroisoxazole derivatives and their use as immunomodulators and antiproliferative agents

New PCOs claimed by Novartis for airways diseases, cardiovascular disorders, urinary incontinence

Novel antibacterial agents from Scriptgen selectively inhibit bacterial RNA polymerase

Pierre Fabre's new 5-HT1A receptor agonists described in recent patent

Growth hormone secretagogues in early development at Pfizer

Structure and biological activity of new glycine-site NMDA receptor antagonist RPR-118723

DDW highlights: prucalopride as an effective and well-tolerated treatment for constipation

SuperGen acquires rights to lucanthone for treatment of brain tumors

New PYY analogue with picomolar affinity for Y4 receptors presented at DDW

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...